Keyword: Zika

Johnson & Johnson has big ambitions in vaccines, and to get there, its manufacturing capacity has to measure up.

Zika vaccine research continues in the absence of a large-scale outbreak, but a shortage of cases is making it hard to test for efficacy.

Here is some other vaccine news of note for the week.

Experts say technology is advancing to develop vaccines faster at a time of increasing emerging disease outbreaks.

Novavax may be years away from a potential approval of its RSV vaccine, but executives aren't waiting to prepare for a possible rollout.

Here's some other vaccine news of note for the week.

Mylan and Biocon win CHMP nod for a Lantus biosimilar, Takeda's Zika vaccine fast-tracked by the FDA, Celltrion got a warning letter.

The WHO stopped classifying Zika as an emergency in late 2016, but Takeda has pressed ahead with its program, winning an FDA fast-track designation.

Here is some other vaccine news of note for the week.